Case | Author | Gender | Age | Chief complaint | Tumor size (cm) | Preoperative diagnosis | Operative method | Immunohistological findings | MI | Miettinen’s criteria [19] | Joensuu’s criteria [20] | Prognosis |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Miyauchi et al. [12] | F | 85 | Vomiting | 9 | GIST | Unresectable (stent implantation) | c-kit (+), CD34 (+), Vimentin (+) | 10 | High risk | Moderate risk | Not described |
2 | Machishi et al. [13] | F | 61 | Anorexia and back pain | 20 | Posterior mediastinal tumor (suspected leiomyosarcoma) | Gastrectomy and lower esophagectomy and partial resection of lower lobe of lung | c-kit (+), CD34 (+), S-100 (+), NSE (+) | Less than 1 per 10 high power fields | Moderate risk | High risk | No recurrence after 25 months |
3 | Higashi et al. [14] | F | 88 | Dysphagia | 14 | SMT and adenocarcinoma | Total gastrectomy | c-kit (+), CD34 (+), SMA focal (+) | 0–2 per high power field | High risk | High risk | Metastasis after 11 months |
4 | Kim et al. [15] | F | 71 | Chest pain | 10 | Not described | Tumorectomy and wedge resection of right lower lobe | c-kit (+), CD34 (+) | 14 | High risk | High risk | No recurrence after 5 years |
5 | Sugimoto et al. [16] | M | 52 | Physical fatigue and anorexia | 10.5 | SMT | Partial gastrectomy | c-kit (+), CD34 (+) | 5 | Moderate risk | High risk | Not described |
6 | Shiozaki et al. [17] | F | 87 | Nausea | 4.5 | SMT (suspected GIST) | Distal gastrectomy | c-kit (+), CD34 (+) | 7 | Moderate risk | Moderate risk | Not described |
7 | Yin et al. [18] | F | 68 | Dysphagia | 13 | GIST | Partial gastrectomy and lower esophagectomy | c-kit (+), CD34 (+), DOG-1 (+) | 18 | High risk | High risk | No recurrence after 48 months |
8 | Our case | F | 81 | Chest discomfort | 14 | SMT | Total gastrectomy and lower esophagectomy | c-kit (+), CD34 (+), vimentin (+) | 2 | Moderate risk | High risk | No recurrence after 24 months |